CLINICAL_TRIALS
trial_result
· 2022-11-03
Clinical Trial Update: Effectiveness of Fecal Flora Alteration for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization [Phase 2, Phase 3]
Summary
A phase 2/3 trial evaluating fecal flora alteration to eradicate carbapenemase-producing Enterobacteriaceae colonization is suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Susy Hota | Conditions: Infection | Phase 2, Phase 3 | Status: SUSPENDED